Driving patient safety, reliable product traceability, aiding the fight against counterfeiting, reducing fraud and complying with European regulations are key priorities for pharmaceutical manufacturers, distributors, dispensers, and governments. European regulators and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have implemented serialisation of prescription drugs (by the manufacturer) with systematic control at the point of dispense (Pharmacy or Hospital), to solve the aforementioned sectoral priorities, aiming at balancing efficiency (ensuring patient safety) and cost control. Product serialisation at the saleable unit is the foundation upon which PharmaLedger will be built.
Blockchain Enabled Healthcare
Vision
The PharmaLedger project will create a scalable blockchain platform validated through reference use cases in supply chain, clinical trials and health data that will serve trendsetters in the industry, thus enabling early adopters.
PharmaLedger will serve as a single source of truth for the healthcare ecosystem and will be designed for efficient decentralised governance, wide adoption by the stakeholders of the ecosystem, compliance with extant and emerging standards and regulation, and end-to-end connectivity and interoperability.
Clinical Trials are fundamental to the advancement of medical science. PharmaLedger aims at accelerating clinical development and the submission process by providing an end-to-end clinical trial solution. This will provide transparency, auditability/traceability and fine-grain access control on all aspects of the clinical trial conduct with various stakeholders, including patients and regulators.
Access to health data is critical to a well-functioning healthcare system. Health data are needed to deliver the right care at the right time, discover new medicines, test their safety and effectiveness in clinical trials, and monitor real world usage. Yet friction exists throughout the health system that makes access to health data a challenge. These impediments lead to the data being stuck in silos or fragmented throughout the value chain.
Follow Us
Subscribe
Sign up for our monthly newsletter to stay up to date on all our information, news and activities in just one email a month! Unsubscribe at any time.
Contact Us
Maria Eugenia Beltran
Project Coordinator – UPM
Daniel Fritz
Industry Project Leader – Novartis